Recommendations Developed for Management of Hidradenitis Suppurativa

WEDNESDAY, Oct. 28, 2026 (HealthDay News) -- Evidence-based recommendations are presented for the management of hidradenitis suppurativa (HS) in guidelines of care issued by the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation and published online Oct. 20 in the Journal of the American Academy of Dermatology.Haley B. Naik, M.D., from the University of California in San Francisco, and colleagues conducted a systematic review to provide evidence-based recommendations for the management of HS.The authors presented 37 evidence-based recommendations. Adalimumab, bimekizumab, infliximab, secukinumab, and routine pain assessment were strongly recommended. Conditional recommendations included use of topical therapies (clindamycin, resorcinol, and ruxolitinib), as well as systemic antibiotics (oral doxycycline, tetracycline, clindamycin with rifampin, and intravenous ertapenem). In addition, there were conditional recommendations for hormone therapy with spironolactone, short-term systemic corticosteroids, and upadacitinib. Specific procedural interventions, tobacco cessation, supportive pain management, and zinc supplementation and vitamin D repletion were also conditionally recommended."These guidelines establish an evidence-based standard of care for HS, giving patients, dermatologists, and payers a shared roadmap for what high-quality HS care looks like," Naik said in a statement. "Every person living with HS deserves care that meets this standard."Abstract/Full Text (subscription or payment may be required).Sign up for our weekly HealthDay newsletter

Recommendations Developed for Management of Hidradenitis Suppurativa

Related Stories

Home Run For Health: Baseball Legend CC Sabathia's Heart Scare Puts Focus On Cholesterol

ASA: Propofol Requirements for Endoscopy May Vary With Cannabis Consumption Route

Surrogates Less Likely to Recommend Life-Sustaining Treatment for Patients With Dementia

GLP-1s Show Benefit For Kids With Type 2 Diabetes